Table 1 Correlation between COL9A3/COL6A5 protein expression and clinicopathologic characteristics of GC.

From: USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3/COL6A5 stabilisation

Characteristics

Total (n = 94)

COL9A3

P value

COL6A5

P value

Low

High

Low

High

Age (years)

   

0.913

  

0.613

<55

25

9

16

 

8

17

 

≥55

69

24

45

 

26

43

 

Gender

   

0.238

  

0.359

Male

39

11

28

 

12

27

 

Female

55

22

33

 

22

33

 

Differentiation

   

0.006

  

0.002

Well

28

16

12

 

17

11

 

Moderate

33

11

22

 

11

22

 

Poor

33

6

27

 

6

27

 

Lymph node metastasis

  

<0.001

  

<0.001

Positive

71

16

55

 

17

54

 

Negative

23

17

6

 

17

6

 

Tumour size (cm3)

  

<0.001

  

<0.001

<10

23

19

4

 

19

4

 

≥10

71

15

56

 

15

56

 

AJCC T stage

  

<0.001

  

<0.001

T1, T2

14

12

2

 

12

2

 

T3, T4

80

21

59

 

22

58

 

Clinical TNM stage

  

<0.001

  

<0.001

I, II

38

26

12

 

26

12

 

III, IV

56

7

49

 

8

48